Arkolith/Insider Trading/OCX/Form 4

Broadwood Partners, L.P.

10% OwnerOncocyte Corp (OCX) · full profile →Form 4 · filed Feb 10, 2025
Net Buying
Open-Market Buys
$10.6M
Open-Market Sells
$0
Net Open-Market Flow
$10.6M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2025Buy(P)0—$011.4M
Feb 6, 2025Buy(P)0—$06.9M
Feb 6, 2025Buy(P)660K$2.05$1.4M6.9M
Feb 6, 2025Buy(P)4.5M$2.05$9.2M11.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-25-000922) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML